Requires practitioners to discuss risks with patients prescribed opioids or schedule II controlled substances; mandates guidelines for such.
This bill mandates that healthcare practitioners discuss specific risks with patients before prescribing schedule II controlled substances or opioid analgesics. These discussions must cover addiction risks, overdose dangers, and the hazards of combining opioids with alcohol or other depressants. Practitioners must also inform patients about alternative treatments and the risks of exceeding prescribed doses or mixing substances. The Department of Health is required to develop guidelines for these discussions.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.